DK1268468T3 - 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2pyridyl)quinazolinmesylat og polymorfer - Google Patents

4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2pyridyl)quinazolinmesylat og polymorfer

Info

Publication number
DK1268468T3
DK1268468T3 DK01908029T DK01908029T DK1268468T3 DK 1268468 T3 DK1268468 T3 DK 1268468T3 DK 01908029 T DK01908029 T DK 01908029T DK 01908029 T DK01908029 T DK 01908029T DK 1268468 T3 DK1268468 T3 DK 1268468T3
Authority
DK
Denmark
Prior art keywords
tetrahydroisoquinol
methanesulfonamido
polymorphs
dimethoxy
pyridyl
Prior art date
Application number
DK01908029T
Other languages
Danish (da)
English (en)
Inventor
Patricia Ann Basford
Paul Blaise Hodgson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005200A external-priority patent/GB0005200D0/en
Priority claimed from GB0015900A external-priority patent/GB0015900D0/en
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK1268468T3 publication Critical patent/DK1268468T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01908029T 2000-03-03 2001-02-23 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2pyridyl)quinazolinmesylat og polymorfer DK1268468T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0005200A GB0005200D0 (en) 2000-03-03 2000-03-03 New salt form
GB0015900A GB0015900D0 (en) 2000-06-28 2000-06-28 New salt form
PCT/IB2001/000244 WO2001064672A1 (en) 2000-03-03 2001-02-23 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs

Publications (1)

Publication Number Publication Date
DK1268468T3 true DK1268468T3 (da) 2004-02-09

Family

ID=26243792

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01908029T DK1268468T3 (da) 2000-03-03 2001-02-23 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2pyridyl)quinazolinmesylat og polymorfer

Country Status (40)

Country Link
US (1) US6683085B2 (ko)
EP (1) EP1268468B1 (ko)
JP (1) JP3857919B2 (ko)
KR (1) KR100496089B1 (ko)
CN (1) CN1214029C (ko)
AP (1) AP2002002611A0 (ko)
AR (1) AR029482A1 (ko)
AT (1) ATE253570T1 (ko)
AU (1) AU779118B2 (ko)
BG (1) BG106869A (ko)
BR (1) BR0108910A (ko)
CA (1) CA2398963C (ko)
CR (1) CR6731A (ko)
CZ (1) CZ20022858A3 (ko)
DE (1) DE60101157T2 (ko)
DK (1) DK1268468T3 (ko)
EA (1) EA004748B1 (ko)
EE (1) EE200200496A (ko)
ES (1) ES2208565T3 (ko)
GE (1) GEP20043364B (ko)
HK (1) HK1053655A1 (ko)
HN (1) HN2001000036A (ko)
HR (1) HRP20020718A2 (ko)
HU (1) HUP0300006A3 (ko)
IL (1) IL150634A0 (ko)
IS (1) IS6441A (ko)
MA (1) MA26876A1 (ko)
MX (1) MXPA02008665A (ko)
NO (1) NO20024195L (ko)
NZ (1) NZ519672A (ko)
OA (1) OA12186A (ko)
PE (1) PE20011225A1 (ko)
PL (1) PL365070A1 (ko)
PT (1) PT1268468E (ko)
SI (1) SI1268468T1 (ko)
SK (1) SK12282002A3 (ko)
TN (1) TNSN01034A1 (ko)
TR (1) TR200302130T4 (ko)
UA (1) UA72311C2 (ko)
WO (1) WO2001064672A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163696B2 (en) 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
GB0124455D0 (en) * 2001-10-11 2001-12-05 Pfizer Ltd Pharmaceutical formulations
DE10223913A1 (de) * 2002-05-29 2003-12-11 Bayer Cropscience Ag Verfahren zur Herstellung spezifischer Kristallmodifikationen polymorpher Substanzen
GB0221582D0 (en) * 2002-09-17 2002-10-23 Pfizer Ltd Method of treatment
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2005089804A2 (en) * 2004-03-16 2005-09-29 Pfizer Limited Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists
CN101584696A (zh) * 2008-05-21 2009-11-25 上海艾力斯医药科技有限公司 包含喹唑啉衍生物的组合物及制备方法、用途
CN105596301A (zh) * 2016-01-29 2016-05-25 中国药科大学 一种以异喹啉为基本骨架的p2x7受体拮抗剂的纳米混悬剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914114A (en) 1984-05-28 1990-04-03 Merck Patent Gesellschaft Mit Breschrankter Haftung 3-[4-(4-phenyl-1,2,3,6-tetrahydro-1-pyridyl)butyl]-5-hydroxy-indole methanesulfonate having sedating and anti-parkinsonism properties
JPH0822859B2 (ja) * 1986-09-16 1996-03-06 メルク・パテント・ゲゼルシヤフト ミツト・ベシユレンクテル・ハフツング ヒドロキシインドール誘導体
GB9700504D0 (en) * 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
UA72311C2 (uk) 2005-02-15
JP2003525289A (ja) 2003-08-26
MXPA02008665A (es) 2003-02-24
AU3588801A (en) 2001-09-12
IL150634A0 (en) 2003-02-12
WO2001064672A1 (en) 2001-09-07
BG106869A (bg) 2002-12-29
AR029482A1 (es) 2003-07-02
NO20024195D0 (no) 2002-09-03
CA2398963A1 (en) 2001-09-07
IS6441A (is) 2002-06-25
US20020010188A1 (en) 2002-01-24
HK1053655A1 (en) 2003-10-31
DE60101157T2 (de) 2004-09-02
US6683085B2 (en) 2004-01-27
EA200200826A1 (ru) 2003-02-27
JP3857919B2 (ja) 2006-12-13
KR100496089B1 (ko) 2005-06-17
HUP0300006A2 (en) 2003-05-28
EA004748B1 (ru) 2004-08-26
EP1268468A1 (en) 2003-01-02
PL365070A1 (en) 2004-12-27
BR0108910A (pt) 2002-12-24
CN1214029C (zh) 2005-08-10
ATE253570T1 (de) 2003-11-15
PT1268468E (pt) 2004-01-30
NO20024195L (no) 2002-09-03
KR20020080463A (ko) 2002-10-23
EP1268468B1 (en) 2003-11-05
SK12282002A3 (sk) 2003-10-07
CN1432010A (zh) 2003-07-23
GEP20043364B (en) 2004-03-10
PE20011225A1 (es) 2001-12-08
AU779118B2 (en) 2005-01-06
HRP20020718A2 (en) 2004-02-29
HN2001000036A (es) 2001-07-09
EE200200496A (et) 2004-02-16
MA26876A1 (fr) 2004-12-20
CA2398963C (en) 2006-10-24
ES2208565T3 (es) 2004-06-16
DE60101157D1 (de) 2003-12-11
CZ20022858A3 (cs) 2003-09-17
TNSN01034A1 (fr) 2005-11-10
NZ519672A (en) 2004-06-25
SI1268468T1 (en) 2004-04-30
TR200302130T4 (tr) 2004-01-21
AP2002002611A0 (en) 2002-09-30
CR6731A (es) 2004-03-11
OA12186A (en) 2006-05-09
HUP0300006A3 (en) 2006-01-30

Similar Documents

Publication Publication Date Title
NO20024308D0 (no) Arylsubstituerte pyridiner, pyrimidiner og triaziner og deres anvendelse
DK1341774T3 (da) Kondenserede heteroaromatiske glucokinase-aktivatorer
IS7227A (is) Salt form af E-2-metoxí-N-(3-(4-(3-metýl-pýridín-3-yloxýl)-fenýlamínó)-kínasólín-6-yl)-allýl)-asetamíð, framleiðsla þess og notkun gegn krabbameini
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
DE60234376D1 (de) 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimin-nucleoside und ihre verwendung
IS6524A (is) 5-alkýlpyrídó(3-3-D)pyrimídín týrósín kínasa tálmar
DK1480983T3 (da) Heteroarylsubstituerede 2-pyridinyl- og 2-pyrimidinyl- 6,7,8,9-tetrahydropyrimido[1,2a]pyrimidin-4-onderivater
NO20024874L (no) Benzoamidpiperidin-inneholdende forbindelser og beslektede forbindelser
IS7017A (is) Tengd pýrazínon, pýridín og pýrimídín sem bindlarlosunarþátts kortíkótrópíns
ATE303388T1 (de) Substituierte 2-pyridinyl-6,7,8,9- tetrahydropyrimidoc1,2-aöpyrimidin-4-on- und 7- pyridinyl-2,3-dihydroimidazo-c1,2-aöpyrimidin- 5(1h)onderivate
NO20024152D0 (no) Gjengeforbindelse og fjellborelement
ATE253561T1 (de) 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-( - morpholin-4-yl-4-o-tolyl-pyridin-3-yl)- isobutyramid
DK1268468T3 (da) 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2pyridyl)quinazolinmesylat og polymorfer
NO20040404L (no) 2- (3,5-bis-trifluorometyl-fenyl) - N - [6-(1,1-diokso-1lam bda6-tiomorfolin-4-yl) - 4 - (2-metyl- eller 4-fluor-2-metylsubstituert) fenyl-pyridin-3-yl] -N-metyl-isobutyrami.
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater
NO20041520L (no) Farmasoytiske formuleringer for kontrollert frigjoring av 4-amino-6,7-dimetoksy-2- (5-metansulfonamido-1,2,3,4-tetrahydroisokinol-2-yl) -5- (2-pyridyl) kinazolin.
HK1062683A1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(E)-=-methyloxime and its salts.
NO20025135L (no) Antihypertensive midler og anvendelse
HK1061392A1 (en) 5-'4-'2-(N-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione mesylate salt
DK1274700T3 (da) Dihydrobenzopyraner, dihydrobenzothiopyraner og tetrahydroquinoliner til behandling af COX-2-medierede lidelser
IT249203Y1 (it) Dispositivo a binario e cursore per la realizzazione di elementi decorativi a configurazione variabile, su oggetti personali e/o d'arredo.
ITRM20000220A0 (it) Cinnamilidenidrazide isonicotinica c15h13n3o